biote Corp. (OTCPK:FSNUF) Q4 2023 Earnings Conference Call March 12, 2024 5:00 PM ET

Company Participants

Simon Serowiecki - Investor Relations

Terry Weber - Chief Executive Officer

Bob Peterson - Chief Financial Officer

Marc Beer - Executive Chairman

Dr. Ross McQuivey - Chief Medical Officer

Conference Call Participants

Les Sulewski - Truist Securities

Jonna Kim - TD Cowen

Richard Magnusen - B. Riley & Co.

Kaumil Gajrawala - Jefferies

Operator

Good afternoon, and welcome to the biote Fourth Quarter and Full Year 2023 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.

I would now like to turn the conference over to Simon Serowiecki, IR representative from Advisory Partners. Please go ahead.

Simon Serowiecki

Thank you for joining us today. This evening, biote published financial results for the quarter and full year ended December 31, 2023. This news release is available on the Investor Relations section of the company's website. Terry Weber, Chief Executive Officer; and Bob Peterson, Chief Financial Officer, will host today's call.

Before we get started, I would like to remind everyone that management will make statements during this call that include forward-looking statements regarding, among other things, the company's financial results, future performance and growth opportunities, business outlook, strategies, goals, manufacturing and commercialization activities, business operations, the impact of macroeconomic conditions on its business, results of operations, financial conditions and other matters.

These statements are not guarantees of future performance. They are subject to a variety of risks and uncertainties, some of which are beyond the company's control. Actual results could differ materially from expectations reflected in any forward-looking statements. These statements are subject to risks and uncertainties and assumptions that are based on management's current expectations as of today. Biote undertakes no obligation to update them in the future, therefore, these statements should not be relied upon as representing the company's views as of any subsequent date.

For a discussion of risks and other important factors that could affect our actual results, please refer to our SEC filings available on the SEC's website and the Investor Relations section of our website as well as risks and other important factors discussed in the earnings release. Management will also refer to adjusted EBITDA, which is a non-GAAP financial measure to provide additional information to investors. A reconciliation of the non-GAAP to GAAP measures is provided in our earnings release, with the primary differences being stock-based compensation, fair value adjustments of certain liabilities, transaction-related expenses and other non-operating expenses.